| Challenges and opportunities in dermal/transdermal delivery KS Paudel, M Milewski, CL Swadley, NK Brogden, P Ghosh, ... Therapeutic delivery 1 (1), 109-131, 2010 | 657 | 2010 |
| Heat effects on drug delivery across human skin J Hao, P Ghosh, SK Li, B Newman, GB Kasting, SG Raney Expert opinion on drug delivery 13 (5), 755-768, 2016 | 96 | 2016 |
| Diclofenac delays micropore closure following microneedle treatment in human subjects NK Brogden, M Milewski, P Ghosh, L Hardi, LJ Crofford, AL Stinchcomb Journal of controlled release 163 (2), 220-229, 2012 | 79 | 2012 |
| In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin M Milewski, TR Yerramreddy, P Ghosh, PA Crooks, AL Stinchcomb Journal of controlled release 146 (1), 37-44, 2010 | 62 | 2010 |
| In vitro–in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence … SH Shin, S Thomas, SG Raney, P Ghosh, DC Hammell, SS El-Kamary, ... Journal of Controlled Release 270, 76-88, 2018 | 44 | 2018 |
| Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin P Ghosh, NK Brogden, AL Stinchcomb Journal of pharmaceutical sciences 103 (2), 652-660, 2014 | 35 | 2014 |
| Navigating sticky areas in transdermal product development C Strasinger, SG Raney, DC Tran, P Ghosh, B Newman, ED Bashaw, ... Journal of controlled release 233, 1-9, 2016 | 29 | 2016 |
| On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with … SH Shin, P Ghosh, B Newman, DC Hammell, SG Raney, HE Hassan, ... Pharmaceutical Research 34, 1817-1830, 2017 | 28 | 2017 |
| Development of a codrug approach for sustained drug delivery across microneedle-treated skin P Ghosh, RR Pinninti, DC Hammell, KS Paudel, AL Stinchcomb Journal of pharmaceutical sciences 102 (5), 1458-1467, 2013 | 26 | 2013 |
| Characterization of Temperature Profiles in Skin and Transdermal Delivery System When Exposed to Temperature Gradients In Vivo and In Vitro Q Zhang, M Murawsky, T LaCount, J Hao, GB Kasting, B Newman, ... Pharmaceutical research 34, 1491-1504, 2017 | 25 | 2017 |
| In vitro/in Vivo Correlations in Transdermal Product Development P Ghosh, M Milewski, K Paudel Therapeutic Delivery 6 (9), 1117-1124, 2015 | 25 | 2015 |
| Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: In vitro–in vivo correlation M Milewski, KS Paudel, NK Brogden, P Ghosh, SL Banks, DC Hammell, ... Molecular pharmaceutics 10 (10), 3745-3757, 2013 | 22 | 2013 |
| Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average … SH Shin, E Rantou, SG Raney, P Ghosh, H Hassan, A Stinchcomb Pharmaceutical Research 37, 1-13, 2020 | 21 | 2020 |
| Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery P Ghosh, NK Brogden, AL Stinchcomb Molecular pharmaceutics 10 (6), 2331-2339, 2013 | 20 | 2013 |
| Evaluation of local bioavailability of metronidazole from topical formulations using dermal microdialysis: Preliminary study in a Yucatan mini-pig model BA Kuzma, S Senemar, T Ramezanli, P Ghosh, SG Raney, G Stagni European Journal of Pharmaceutical Sciences 159, 105741, 2021 | 17 | 2021 |
| Modeling temperature-dependent dermal absorption and clearance for transdermal and topical drug applications TD LaCount, Q Zhang, J Hao, P Ghosh, SG Raney, A Talattof, GB Kasting, ... The AAPS journal 22, 1-13, 2020 | 14 | 2020 |
| Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin P Ghosh, DM Lee, KB Kim, AL Stinchcomb Pharmaceutical research 31, 148-159, 2014 | 14 | 2014 |
| Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the … SH Shin, M Yu, DC Hammell, P Ghosh, SG Raney, HE Hassan, ... Journal of Controlled Release 342, 134-147, 2022 | 11 | 2022 |
| Multi‐phase multi‐layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin N Patel, JF Clarke, F Salem, T Abdulla, F Martins, S Arora, E Tsakalozou, ... CPT: Pharmacometrics & Systems Pharmacology 11 (8), 1060-1084, 2022 | 10 | 2022 |
| Correlation of physicochemical characteristics and in vitro permeation test (IVPT) results for acyclovir and metronidazole topical products M Roberts, Y Mohammed, S Namjoshi, N Jung, K Chaitanya, S Cheruvu, ... FDA Workshop on bioequivalence testing of topical drug products, 2017 | 10 | 2017 |
